{"schema":"https://pith.science/schemas/pith-integrity/v1.json","pith_number":"2607.24210","arxiv_id":"2607.24210","integrity":{"available":true,"endpoint":"/pith/2607.24210/integrity.json","summary":{"critical":0,"advisory":5,"informational":0,"by_detector":{"doi_compliance":{"total":5,"critical":0,"advisory":5,"informational":0}}},"clean":false,"detectors_run":[{"name":"doi_title_agreement","version":"1.0.0","status":"completed","ran_at":"2026-08-04T23:08:49.317922Z","findings_count":0},{"name":"doi_compliance","version":"1.1.0","status":"completed","ran_at":"2026-08-04T21:40:48.029429Z","findings_count":5},{"name":"ai_meta_artifact","version":"1.0.0","status":"skipped","ran_at":"2026-08-04T07:08:43.535654Z","findings_count":0},{"name":"claim_evidence","version":"1.0.0","status":"completed","ran_at":"2026-08-03T17:48:23.393290Z","findings_count":0},{"name":"citation_quote_validity","version":"0.1.0","status":"skipped","ran_at":"2026-07-28T15:57:58.452791Z","findings_count":0},{"name":"cited_work_retraction","version":"1.0.0","status":"completed","ran_at":"2026-07-28T10:54:19.779018Z","findings_count":0}],"findings":[{"detector":"doi_compliance","finding_type":"recoverable_identifier","severity":"advisory","verdict_class":"incontrovertible","note":"DOI is split by whitespace or line breaks in the printed bibliography. Reconstructed DOI 10.1093/annonc/mdv562 resolves to 'Statistical controversies in clinical research: end points other than overall survival are vital for regulatory approval'. A reader following the printed text alone cannot reach it.","detected_doi":"10.1093/annonc/mdv562","detected_arxiv_id":null,"ref_index":22,"audited_at":"2026-07-31T21:01:45.436236Z"},{"detector":"doi_compliance","finding_type":"recoverable_identifier","severity":"advisory","verdict_class":"incontrovertible","note":"DOI is split by whitespace or line breaks in the printed bibliography. Reconstructed DOI 10.1016/j.media.2025.103525 resolves to 'The ULS23 challenge: A baseline model and benchmark dataset for 3D universal lesion segmentation in computed tomography'. A reader following the printed text alone cannot reach it.","detected_doi":"10.1016/j.media.2025.103525","detected_arxiv_id":null,"ref_index":3,"audited_at":"2026-07-31T21:01:45.436236Z"},{"detector":"doi_compliance","finding_type":"recoverable_identifier","severity":"advisory","verdict_class":"incontrovertible","note":"DOI in the printed bibliography is fragmented by whitespace or line breaks. A longer candidate (10.48550/arXiv.2311.13385) was visible in the surrounding text but could not be confirmed against doi.org as printed.","detected_doi":"10.48550/arXiv.2311.13385","detected_arxiv_id":null,"ref_index":5,"audited_at":"2026-07-31T21:01:45.436236Z"},{"detector":"doi_compliance","finding_type":"recoverable_identifier","severity":"advisory","verdict_class":"incontrovertible","note":"DOI is split by whitespace or line breaks in the printed bibliography. Reconstructed DOI 10.1016/j.eclinm.2024.102824 resolves to 'Frequently asked questions on surrogate endpoints in oncology-opportunities, pitfalls, and the way forward'. A reader following the printed text alone cannot reach it.","detected_doi":"10.1016/j.eclinm.2024.102824","detected_arxiv_id":null,"ref_index":20,"audited_at":"2026-07-31T21:01:45.436236Z"},{"detector":"doi_compliance","finding_type":"recoverable_identifier","severity":"advisory","verdict_class":"incontrovertible","note":"DOI in the printed bibliography is fragmented by whitespace or line breaks. A longer candidate (10.1117/1.JMI.5.3.036501) was visible in the surrounding text but could not be confirmed against doi.org as printed.","detected_doi":"10.1117/1.JMI.5.3.036501","detected_arxiv_id":null,"ref_index":25,"audited_at":"2026-07-31T21:01:45.436236Z"}],"snapshot_sha256":"3a42b07d82399dc1bf053b81741ffe0def4bd1bf1e1fb79a58ec96fa043b8017"},"events":[{"event_id":14516,"event_type":"pith.integrity.v1","payload_sha256":"e1b89407a5a3271d210713fc94dd1088189abfc3645fe5e375a9221bb07bf1f1","signature_b64":"gVBnaoAb+pNMtfU2XS/PsPxQZ18H4uP3zl3BzdZaLm/WVLXsKLEG0dFGpdcMkyPbm5suQuPpo5Wwfr/Oyv8UCg==","signing_key_id":"pith-v1-2026-05","created_at":"2026-07-31T21:06:18.141420+00:00","payload":{"note":"DOI in the printed bibliography is fragmented by whitespace or line breaks. A longer candidate (10.1117/1.JMI.5.3.036501) was visible in the surrounding text but could not be confirmed against doi.org as printed.","snippet":"Yan, K., Wang, X., Lu, L., Summers, R.M.: DeepLesion: Automated mining of large-scale lesion annotations and universal lesion detection with deep learning. Journal of Medical Imaging 5(3), 036501 (Jul 2018). https://doi.org/10.1117/1. JMI.5","arxiv_id":"2607.24210","detector":"doi_compliance","evidence":{"ref_index":25,"verdict_class":"incontrovertible","resolved_title":null,"printed_excerpt":"10.1117/1","reconstructed_doi":"10.1117/1.JMI.5.3.036501"},"severity":"advisory","ref_index":25,"audited_at":"2026-07-31T21:01:45.436236Z","event_type":"pith.integrity.v1","detected_doi":"10.1117/1.JMI.5.3.036501","detector_url":"https://pith.science/pith-integrity-protocol#doi_compliance","external_url":null,"finding_type":"recoverable_identifier","evidence_hash":"a2808b16c0a3d83320162db5b2d73de884f1abe3ca79ea17c3b3cbc40035151c","paper_version":1,"verdict_class":"incontrovertible","resolved_title":null,"detector_version":"1.1.0","detected_arxiv_id":null}},{"event_id":14515,"event_type":"pith.integrity.v1","payload_sha256":"489b536811825fd55001bf73faa305315927d7b7dcc0f9a1e4e25cccf44e1cd7","signature_b64":"0OAEYgyrOpnDsvwjHr/WUzOxs5Qbav4/EZobfod3PdHHMaudrKI2fS9pzt0czaqwaGuEqJbfv+H7fLU+srbyCA==","signing_key_id":"pith-v1-2026-05","created_at":"2026-07-31T21:06:17.907875+00:00","payload":{"note":"DOI is split by whitespace or line breaks in the printed bibliography. Reconstructed DOI 10.1093/annonc/mdv562 resolves to 'Statistical controversies in clinical research: end points other than overall survival are vital for regulatory approval'. A reader following the printed text alone cannot reach it.","snippet":"Saad, E.D., Buyse, M.: Statistical controversies in clinical research: End points other than overall survival are vital for regulatory approval of anticancer agents. Annals of Oncology 27(3), 373–378 (Mar 2016). https://doi.org/10.1093/anno","arxiv_id":"2607.24210","detector":"doi_compliance","evidence":{"ref_index":22,"verdict_class":"incontrovertible","resolved_title":"Statistical controversies in clinical research: end points other than overall survival are vital for regulatory approval of anticancer agents","printed_excerpt":"10.1093/annonc/","reconstructed_doi":"10.1093/annonc/mdv562"},"severity":"advisory","ref_index":22,"audited_at":"2026-07-31T21:01:45.436236Z","event_type":"pith.integrity.v1","detected_doi":"10.1093/annonc/mdv562","detector_url":"https://pith.science/pith-integrity-protocol#doi_compliance","external_url":null,"finding_type":"recoverable_identifier","evidence_hash":"2e48738062f5f46d7da59c3a46a7f4325b9b9c7276c189057a0f94eca6e197c7","paper_version":1,"verdict_class":"incontrovertible","resolved_title":"Statistical controversies in clinical research: end points other than overall survival are vital for regulatory approval of anticancer agents","detector_version":"1.1.0","detected_arxiv_id":null}},{"event_id":14514,"event_type":"pith.integrity.v1","payload_sha256":"289b62c266938f25c5c47e3479e862a951e4ade5e9054d809ddbbf275e49ca56","signature_b64":"e5yK5+b9eFA+1mIFwl8A+8IX4rihj9qbZNbEjUuib5GQjkFRivJHDVdxW37Y9pLtxz5VLQyY2cnMdqCEuaPZAw==","signing_key_id":"pith-v1-2026-05","created_at":"2026-07-31T21:06:17.713944+00:00","payload":{"note":"DOI is split by whitespace or line breaks in the printed bibliography. Reconstructed DOI 10.1016/j.eclinm.2024.102824 resolves to 'Frequently asked questions on surrogate endpoints in oncology-opportunities, pitfalls, and the way forward'. A reader following the printed text alone cannot reach it.","snippet":"Mittal, A., Kim, M.S., Dunn, S., Wright, K., Gyawali, B.: Frequently asked questions on surrogate endpoints in oncology-opportunities, pitfalls, and the way forward. eClinicalMedicine 76 (Oct 2024). https://doi.org/10.1016/j.eclinm.2024. 10","arxiv_id":"2607.24210","detector":"doi_compliance","evidence":{"ref_index":20,"verdict_class":"incontrovertible","resolved_title":"Frequently asked questions on surrogate endpoints in oncology-opportunities, pitfalls, and the way forward","printed_excerpt":"10.1016/j.eclinm.2024","reconstructed_doi":"10.1016/j.eclinm.2024.102824"},"severity":"advisory","ref_index":20,"audited_at":"2026-07-31T21:01:45.436236Z","event_type":"pith.integrity.v1","detected_doi":"10.1016/j.eclinm.2024.102824","detector_url":"https://pith.science/pith-integrity-protocol#doi_compliance","external_url":null,"finding_type":"recoverable_identifier","evidence_hash":"f6e4ec593642a4eab84e73580fef17227532863ed4bb616bd30891a4976d158c","paper_version":1,"verdict_class":"incontrovertible","resolved_title":"Frequently asked questions on surrogate endpoints in oncology-opportunities, pitfalls, and the way forward","detector_version":"1.1.0","detected_arxiv_id":null}},{"event_id":14513,"event_type":"pith.integrity.v1","payload_sha256":"8947a11695f977ed2388c37dc756473316a2cedd6fb14a5481ff386536995b2c","signature_b64":"VgLq8jaOz8lIF8cchZM4Q/Gf9SFqeip629W96ibWVGeK8aATWnVJY0ii9/kWhdXcyp3eOYUxm46KkExMmBmvAQ==","signing_key_id":"pith-v1-2026-05","created_at":"2026-07-31T21:06:17.548540+00:00","payload":{"note":"DOI in the printed bibliography is fragmented by whitespace or line breaks. A longer candidate (10.48550/arXiv.2311.13385) was visible in the surrounding text but could not be confirmed against doi.org as printed.","snippet":"Du, Y., Bai, F., Huang, T., Zhao, B.: SegVol: Universal and Interactive Volumet- ric Medical Image Segmentation (Feb 2025). https://doi.org/10.48550/arXiv.2311. 13385","arxiv_id":"2607.24210","detector":"doi_compliance","evidence":{"ref_index":5,"verdict_class":"incontrovertible","resolved_title":null,"printed_excerpt":"10.48550/arxiv.2311","reconstructed_doi":"10.48550/arXiv.2311.13385"},"severity":"advisory","ref_index":5,"audited_at":"2026-07-31T21:01:45.436236Z","event_type":"pith.integrity.v1","detected_doi":"10.48550/arXiv.2311.13385","detector_url":"https://pith.science/pith-integrity-protocol#doi_compliance","external_url":null,"finding_type":"recoverable_identifier","evidence_hash":"97ce870c25d7c2cb4e96defbbaa3f332dd9bf22500af6df54ece201734445d40","paper_version":1,"verdict_class":"incontrovertible","resolved_title":null,"detector_version":"1.1.0","detected_arxiv_id":null}},{"event_id":14512,"event_type":"pith.integrity.v1","payload_sha256":"f388322b94ad70256c5b9a195440ca3a78f08b9ad38314a0ee1ce052a89cd0e6","signature_b64":"TKxp4EoiYsM6clIY3VDVXn61O2+c9P7UPvA92BXmd2OwQpvTQrEy7kxM86lqJW4xvoxDVTVsd/e6N7DthAIdCQ==","signing_key_id":"pith-v1-2026-05","created_at":"2026-07-31T21:06:17.388177+00:00","payload":{"note":"DOI is split by whitespace or line breaks in the printed bibliography. Reconstructed DOI 10.1016/j.media.2025.103525 resolves to 'The ULS23 challenge: A baseline model and benchmark dataset for 3D universal lesion segmentation in computed tomography'. A reader following the printed text alone cannot reach it.","snippet":"de Grauw, M.J.J., Scholten, E.Th., Smit, E.J., Rutten, M.J.C.M., Prokop, M., van Ginneken, B., Hering, A.: The ULS23 challenge: A baseline model and benchmark dataset for 3D universal lesion segmentation in computed tomography. Medical Imag","arxiv_id":"2607.24210","detector":"doi_compliance","evidence":{"ref_index":3,"verdict_class":"incontrovertible","resolved_title":"The ULS23 challenge: A baseline model and benchmark dataset for 3D universal lesion segmentation in computed tomography","printed_excerpt":"10.1016/j.media.2025","reconstructed_doi":"10.1016/j.media.2025.103525"},"severity":"advisory","ref_index":3,"audited_at":"2026-07-31T21:01:45.436236Z","event_type":"pith.integrity.v1","detected_doi":"10.1016/j.media.2025.103525","detector_url":"https://pith.science/pith-integrity-protocol#doi_compliance","external_url":null,"finding_type":"recoverable_identifier","evidence_hash":"af1981f318471690fae3aa49b8f552c04e16117d1732618e44001ab81a397c9e","paper_version":1,"verdict_class":"incontrovertible","resolved_title":"The ULS23 challenge: A baseline model and benchmark dataset for 3D universal lesion segmentation in computed tomography","detector_version":"1.1.0","detected_arxiv_id":null}}],"endpoint_self":"/pith/2607.24210/integrity.json","protocol_url":"https://pith.science/pith-integrity-protocol"}